Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rimed is a privately held medical device company focused on non-invasive transcranial Doppler and neurovascular ultrasound systems for cerebrovascular diagnosis and monitoring. Founded in 1982 by Joseph Adlin, the company develops, manufactures, and markets transcranial Doppler products including Digi-Lite, Digi-One, Digi-Lite IP+, and the LMY-3 headset, along with its proprietary Auto-Track signal-tracking software. Rimed positions itself as a specialist in neurosonology and stroke-unit workflows, with products used in neurology, neuro ICU, and stroke settings globally. Its systems support applications such as stroke and vasospasm monitoring, right-to-left shunt and patent foramen ovale detection, microembolus detection, brain death assessment, sickle-cell screening, and traumatic brain injury evaluation. The company appears to be an active commercial-stage healthcare business rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rimed.